Immunocore Holdings plc Shareholders' Equity for the year ending December 31, 2024: USD 360.72 M

Immunocore Holdings plc Shareholders' Equity is USD 360.72 M for the year ending December 31, 2024, a -2.20% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Immunocore Holdings plc Shareholders' Equity for the year ending December 31, 2023 was USD 368.84 M, a 9.48% change year over year.
  • Immunocore Holdings plc Shareholders' Equity for the year ending December 31, 2022 was USD 336.90 M, a 45.12% change year over year.
  • Immunocore Holdings plc Shareholders' Equity for the year ending December 31, 2021 was USD 232.14 M, a 207.14% change year over year.
  • Immunocore Holdings plc Shareholders' Equity for the year ending December 31, 2020 was USD 75.58 M, a 286.17% change year over year.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory